BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oloomi M, Moazzezy N, Bouzari S. Comparing blood versus tissue-based biomarkers expression in breast cancer patients. Heliyon 2020;6:e03728. [PMID: 32274439 DOI: 10.1016/j.heliyon.2020.e03728] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Obata K, Yutori H, Yoshida K, Sakamoto Y, Ono K, Ibaragi S. Relationships between squamous cell carcinoma antigen and cytokeratin 19 fragment values and renal function in oral cancer patients. Int J Oral Maxillofac Surg 2022:S0901-5027(22)00353-8. [PMID: 36096859 DOI: 10.1016/j.ijom.2022.08.019] [Reference Citation Analysis]
2 Guven DC, Sahin TK, Erul E, Cakir IY, Ucgul E, Yildirim HC, Aktepe OH, Erman M, Kilickap S, Aksoy S, Yalcin S. The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy. JCM 2022;11:4523. [DOI: 10.3390/jcm11154523] [Reference Citation Analysis]
3 Nicolás-morales ML, Luisa-sanjuan A, Gutiérrez-torres M, Vences-velázquez A, Ortuño-pineda C, Espinoza-rojo M, Navarro-tito N, Cortés-sarabia K. Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review. Vaccines 2022;10:1249. [DOI: 10.3390/vaccines10081249] [Reference Citation Analysis]
4 Anoop TM, Joseph P R, Soman S, Chacko S, Mathew M. Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study. World J Clin Oncol 2022; 13(6): 529-539 [DOI: 10.5306/wjco.v13.i6.529] [Reference Citation Analysis]
5 Quiroz TS, Heras FL. Medicina de precisión: rol de la anatomía patológica en diagnóstico y tratamiento personalizado. Revista Médica Clínica Las Condes 2022;33:36-43. [DOI: 10.1016/j.rmclc.2022.01.003] [Reference Citation Analysis]
6 Daphne Teh AL, Jayapalan JJ, Loke MF, Wan Abdul Kadir AJ, Subrayan V. Identification of potential serum metabolic biomarkers for patient with keratoconus using untargeted metabolomics approach. Exp Eye Res 2021;211:108734. [PMID: 34428458 DOI: 10.1016/j.exer.2021.108734] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Vestergaard LK, Oliveira DNP, Høgdall CK, Høgdall EV. Next Generation Sequencing Technology in the Clinic and Its Challenges. Cancers (Basel) 2021;13:1751. [PMID: 33916923 DOI: 10.3390/cancers13081751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pasvenskaite A, Liutkeviciene R, Gedvilaite G, Vilkeviciute A, Liutkevicius V, Uloza V. Impact of IL-10 Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate. Cancer Genomics Proteomics 2021;18:53-65. [PMID: 33419896 DOI: 10.21873/cgp.20241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Harwansh RK, Deshmukh R. Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs. Crit Rev Oncol Hematol 2020;154:103070. [PMID: 32871325 DOI: 10.1016/j.critrevonc.2020.103070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]